EUVIMEDEUVIMED entdecken
Crossref

Efficacy and safety of non-pegylated liposomal doxorubicin in metastatic breast cancer therapy

Elżbieta Wójcik, Joanna Kufel-Grabowska, Joanna Gierba-Tomczyk

OncoReview · 2017

DOI: 10.24292/01.or.131217 ↗

Kurz gefasst

Fachartikel in der Zeitschrift OncoReview, 2017. Verfasst von Elżbieta Wójcik und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Wójcik, E., Kufel-Grabowska, J., & Gierba-Tomczyk, J. (2017). Efficacy and safety of non-pegylated liposomal doxorubicin in metastatic breast cancer therapy. OncoReview. https://doi.org/10.24292/01.or.131217

Vancouver

Wójcik E, Kufel-Grabowska J, Gierba-Tomczyk J. Efficacy and safety of non-pegylated liposomal doxorubicin in metastatic breast cancer therapy. OncoReview. 2017. doi:10.24292/01.or.131217

BibTeX
@article{Wjcik2017,
  author = {Wójcik, Elżbieta and Kufel-Grabowska, Joanna and Gierba-Tomczyk, Joanna},
  title = {Efficacy and safety of non-pegylated liposomal doxorubicin in metastatic breast cancer therapy},
  journal = {OncoReview},
  year = {2017},
  doi = {10.24292/01.or.131217}
}
Kostenlos starten →